{"meta":{"query_hash":"5fa6b88e9eac","filters":{"venue":"Biopharma Dealmakers"},"cohort_total":4,"direct_labels_cover":0,"predictions_cover":4,"exported":4,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/5fa6b88e9eac","api":"https://metacan.xera.ac/api/v1/cohort?venue=Biopharma+Dealmakers"},"results":[{"id":"W4379013809","doi":"10.1038/d43747-023-00062-8","title":"A formula for drug licensing deals","year":2023,"lang":"en","type":"article","venue":"Biopharma Dealmakers","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"","keywords":"Value (mathematics); Mathematical model; Computer science; Management science; Mathematical economics; Mathematics; Econometrics; Statistics; Engineering","score_opus":0.026615124406594245,"score_gpt":0.3284197357351395,"score_spread":0.30180461132854525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379013809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.914464,0.0008762278,0.00040903216,0.077467434,0.000929737,0.0010335405,0.000021138678,0.0013346991,0.003464203],"genre_scores_gemma":[0.98228234,0.0008249772,0.0019216365,0.0041891043,0.00022021198,0.00005075268,0.000066880304,0.0000430172,0.0104011055],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991357,0.000010063969,0.00018453652,0.00021050948,0.00009787747,0.00036134338],"domain_scores_gemma":[0.99953896,0.00007770367,0.000047141304,0.00017591333,0.000051999235,0.00010830258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020315532,0.00011947266,0.00020186172,0.00020209793,0.00014577089,0.000007932122,0.000065638094,0.00092248747,0.000051099145],"category_scores_gemma":[0.00006198535,0.000099946126,0.00013485242,0.00044508785,0.00007662099,0.000035274556,0.000032425916,0.0006304954,0.0004713501],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001313189,0.00016012852,0.0022322163,0.0005377517,0.00070984697,0.00055095105,0.0009841543,0.00001817532,0.22983065,0.009366842,0.7030682,0.05122792],"study_design_scores_gemma":[0.005982776,0.00017790051,0.004652426,0.00020247654,0.00035200332,0.00031360626,0.0007150784,0.0048221033,0.15848203,0.00055485114,0.8233575,0.00038719468],"about_ca_topic_score_codex":0.000008918487,"about_ca_topic_score_gemma":0.0000014362017,"teacher_disagreement_score":0.12028938,"about_ca_system_score_codex":0.000028038377,"about_ca_system_score_gemma":0.000051577503,"threshold_uncertainty_score":0.71150684},"labels":[],"label_agreement":null},{"id":"W4399300384","doi":"10.1038/d43747-024-00027-5","title":"Top ten biopharma deals of 2024","year":2024,"lang":"en","type":"article","venue":"Biopharma Dealmakers","topic":"Science, Research, and Medicine","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Value (mathematics); Business; Engineering; Geography; Computer science","score_opus":0.032967318924716695,"score_gpt":0.37500310724981883,"score_spread":0.3420357883251021,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399300384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.941276,0.015763981,0.00008645697,0.007451502,0.0026366874,0.00078502786,0.00006125271,0.00026655613,0.03167255],"genre_scores_gemma":[0.98032373,0.0017184773,0.00041670547,0.001524899,0.0007411683,0.00003099697,0.000020236514,0.00003851126,0.015185299],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976318,0.000043108466,0.00042545577,0.00047460364,0.00085849746,0.00056656107],"domain_scores_gemma":[0.9987453,0.00013408298,0.000049620594,0.0003516428,0.0001643747,0.00055498147],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00079517934,0.0002123038,0.00039617013,0.00057019416,0.000062440304,0.000032493128,0.00021974421,0.00010322754,0.0020857768],"category_scores_gemma":[0.00013692454,0.00015328891,0.00019811944,0.0013241655,0.00039107067,0.00012467516,0.00007995028,0.00033861707,0.0004665954],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004976214,0.00021675143,0.01309312,0.0016608555,0.00033249005,0.002061566,0.0010760393,0.0000023761559,0.6906664,0.0010508156,0.2009676,0.0883744],"study_design_scores_gemma":[0.0041374266,0.00097453635,0.022368515,0.0011782985,0.00047979353,0.0008634722,0.0016006558,0.002606845,0.31458372,0.0001409894,0.6506018,0.00046396072],"about_ca_topic_score_codex":0.00013832086,"about_ca_topic_score_gemma":0.0000017107828,"teacher_disagreement_score":0.4496342,"about_ca_system_score_codex":0.00009852967,"about_ca_system_score_gemma":0.000493879,"threshold_uncertainty_score":0.99882644},"labels":[],"label_agreement":null},{"id":"W4406798987","doi":"10.1038/d43747-024-00141-4","title":"Building a global biotechnology powerhouse in Canada","year":2025,"lang":"en","type":"article","venue":"Biopharma Dealmakers","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Government of New Brunswick","funders":"","keywords":"Biotechnology; Political science; Engineering; Biology","score_opus":0.004728838199284108,"score_gpt":0.26356437334161514,"score_spread":0.25883553514233104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406798987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9038811,0.002217756,0.00029574268,0.08848481,0.00077580626,0.00027113152,0.00000990029,0.00020961065,0.003854198],"genre_scores_gemma":[0.9932271,0.00049157516,0.0009777353,0.0051067146,0.000013081565,0.000009213494,0.0000026145774,0.000007213535,0.00016475664],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99901825,0.000016724836,0.00023940233,0.000275467,0.00009158788,0.0003585449],"domain_scores_gemma":[0.9995992,0.000021031175,0.000038013077,0.00025601152,0.000020859572,0.00006486916],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.000074866526,0.00013943325,0.0002496828,0.00020192949,0.00004703458,0.0000035926166,0.0001459851,0.0015309645,0.000046098106],"category_scores_gemma":[0.00005613072,0.00012705951,0.000045790028,0.000990461,0.00010980717,0.000019260451,0.0000757482,0.001328374,0.000012433194],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018385849,0.0004987661,0.40258613,0.00042943953,0.0011412062,0.008547104,0.00005499929,0.00007921288,0.12879635,0.22497095,0.08357258,0.14748468],"study_design_scores_gemma":[0.0122223105,0.0002481525,0.21004884,0.00076048094,0.00034141322,0.0010166923,0.00086987606,0.0015259103,0.23894258,0.0016607057,0.53153735,0.00082568754],"about_ca_topic_score_codex":0.35542086,"about_ca_topic_score_gemma":0.252813,"teacher_disagreement_score":0.44796476,"about_ca_system_score_codex":0.00077817636,"about_ca_system_score_gemma":0.001284182,"threshold_uncertainty_score":0.9997653},"labels":[],"label_agreement":null},{"id":"W4416852000","doi":"10.1038/d43747-025-00111-4","title":"The year of the bispecific in oncology and beyond","year":2025,"lang":"en","type":"article","venue":"Biopharma Dealmakers","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bispecific antibody; Quarter (Canadian coin); Antibody therapy; Radiation oncology; Momentum (technical analysis)","score_opus":0.015380649526590113,"score_gpt":0.3433365801308608,"score_spread":0.3279559306042707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416852000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9291083,0.0027621451,6.789444e-7,0.02556466,0.00023317903,0.0002615566,0.0000075915814,0.000005260183,0.042056628],"genre_scores_gemma":[0.9887575,0.0017964713,0.00005446647,0.0008478195,0.000040683615,0.000010129918,0.00000133393,0.000004365645,0.008487249],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99935114,0.000063697604,0.00016491699,0.00010882667,0.00014437277,0.00016704349],"domain_scores_gemma":[0.9995255,0.00022034907,0.000030293593,0.00014428335,0.000037710503,0.000041855303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025120142,0.000060442322,0.00013220734,0.000063094805,0.00008752653,0.000006720514,0.00011236602,0.000045662568,0.0000345212],"category_scores_gemma":[0.000052678257,0.000030052748,0.00004960208,0.00028763016,0.00034101878,0.000010839173,0.00010677738,0.00018879607,0.000008592656],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003854071,0.000334401,0.5817443,0.00035268458,0.0002809129,0.00011940624,0.0007614434,0.0000025824438,0.09235609,0.06165382,0.0773824,0.1811579],"study_design_scores_gemma":[0.0012321748,0.0000936191,0.37356457,0.00004431101,0.000018838688,0.000017417167,0.0005077997,0.00007367819,0.007862188,0.00042118775,0.61612177,0.000042465606],"about_ca_topic_score_codex":0.00009076766,"about_ca_topic_score_gemma":0.000053636762,"teacher_disagreement_score":0.5387393,"about_ca_system_score_codex":0.0000386007,"about_ca_system_score_gemma":0.0001544957,"threshold_uncertainty_score":0.1256498},"labels":[],"label_agreement":null}]}